Chargement en cours...
Radiohybrid Ligands: A Novel Tracer Concept Exemplified by (18)F- or (68)Ga-Labeled rhPSMA Inhibitors
When we critically assess the reason for the current dominance of (68)Ga-labeled peptides and peptide-like ligands in radiopharmacy and nuclear medicine, we have to conclude that the major advantage of such radiopharmaceuticals is the apparent lack of suitable (18)F-labeling technologies with proven...
Enregistré dans:
| Publié dans: | J Nucl Med |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Society of Nuclear Medicine
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7198388/ https://ncbi.nlm.nih.gov/pubmed/31862804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.119.234922 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|